SCHEMBL24326675

SCHEMBL24326675

Cc1cccc(C)c1-c1cc(Cl)nc(NSc2cccc(C(=O)N3CCN(Cc4ccccc4)CC(O)C3CC(C)C)c2)n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SCN4A P35499 2/20 0.33
CA1 P00915 4/20 0.32
CA2 P00918 4/20 0.32
CA4 P22748 4/20 0.32
CA9 Q16790 4/20 0.32
KLKB1 P03952 1/20 0.31
ADRB2 P07550 1/20 0.31
CHRM4 P08173 2/20 0.31
OPRM1 P35372 1/20 0.30
OPRK1 P41145 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24325747 1.00 MEN1 (0.33) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL24325424 0.88 SMO (0.33)
SCHEMBL24326673 0.87 ALDH1A1 (0.40) MEN1KMT2ALMNAMAPK1SCN4A
SCHEMBL24326333 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL29570523 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL29570636 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL24326312 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL24325753 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL29570936 0.86 ALDH1A1 (0.40) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL24326262 0.86 ROCK2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed